Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;39(5):e70071.
doi: 10.1002/bmc.70071.

Metabolomics Based Exploration of the Mechanism of Action of Tripterygium Glycosides in Diabetic Kidney Disease

Li Long  1 , Jianfeng Yu  2 , Jingsong Jin  1 , Jibo Zhang  2
Affiliations

Metabolomics Based Exploration of the Mechanism of Action of Tripterygium Glycosides in Diabetic Kidney Disease

Li Long et al. Biomed Chromatogr. 2025 May.

Abstract

Tripterygium glycosides (TGs), the primary active components of Tripterygium wilfordii, have demonstrated therapeutic efficacy in treating diabetic kidney disease (DKD). However, the precise mechanisms underlying their action remain elusive, limiting the full realization of their medicinal potential. This study employed serum metabolomics based on liquid chromatography-mass spectrometry (LC-MS) analysis to elucidate the mechanisms by which TGs combat DKD. We evaluated the protective effects of TGs on DKD following treatment. Serum samples were collected before and after treatment, and their metabolic profiles were analyzed using LC-MS. Our metabolomics analysis revealed that TGs significantly modulated the hedgehog signaling pathway, a key metabolic pathway implicated in DKD pathogenesis. This study represents the first comprehensive investigation of the metabolic pathways regulated by TGs in the context of DKD using a metabolomics approach. Our findings provide a robust theoretical foundation for the more effective utilization and potential combination therapies involving TGs in the management of DKD. These insights pave the way for further research and development of targeted therapeutic strategies for this challenging condition.

Keywords: Tripterygium glycosides; diabetic kidney disease; hedgehog signaling pathway; mechanism; metabolomics.

PubMed Disclaimer

References

    1. Abdelsattar, S., Z. Kasemy, M. Elsayed, T. Elrahem, and S. K. Zewain. 2021. “Targeted Metabolomics as a Tool for the Diagnosis of Kidney Disease in Type II Diabetes Mellitus.” British Journal of Biomedical Science 78, no. 4: 184–190.
    1. Bai, Y., H. Lu, C. Lin, et al. 2016. “Sonic Hedgehog‐Mediated Epithelial‐Mesenchymal Transition in Renal Tubulointerstitial Fibrosis.” International Journal of Molecular Medicine 37, no. 5: 1317–1327. https://doi.org/10.3892/ijmm.2016.2546.
    1. Benzacken, B., J. P. Siffroi, C. Le Bourhis, et al. 1997. “Different Proximal and Distal Rearrangements of Chromosome 7q Associated With Holoprosencephaly.” Journal of Medical Genetics 34, no. 11: 899–903. https://doi.org/10.1136/jmg.34.11.899.
    1. Bikbov, B., C. A. Purcell, A. S. Levey, et al. 2020. “Global, Regional, and National Burden of Chronic Kidney Disease, 1990–2017: A Systematic Analysis for the.” Global Burden of Disease Study 2017 395, no. 10225: 709–733.
    1. Braet, P., G. V. R. Sartò, M. Pirovano, B. Sprangers, and L. J. Cosmai. 2022. “Treatment of Acute Kidney Injury in Cancer Patients.” Clinical Kidney Journal 15, no. 5: 873–884.

LinkOut - more resources